Skip to main content

Advertisement

SpringerLink
Log in

Symptom burden in cancer survivorship

  • Published:
Journal of Cancer Survivorship Aims and scope Submit manuscript

Abstract

Introduction

The subjective experience of cancer survivorship can be assessed by various patient-reported outcome (PRO) methods, including measures of symptom burden and health-related quality of life (HRQOL). Symptom burden includes the presence and severity of multiple symptoms and the level of distress caused by symptoms that go untreated or unrelieved. The concept of symptom burden is more limited in scope than HRQOL but may provide information that better describes the status of various stages of survivorship. This paper contrasts symptom burden with general HRQOL and addresses the importance of including symptom burden as research tool throughout the trajectory of cancer survivorship.

Methods

We summarized studies that illustrate both HRQOL and symptoms as outcomes of treatment and of descriptive studies of cancer survivorship. Survivorship was operationally defined as beginning at the completion of primary anticancer treatment.

Results

HRQOL and symptom burden measures both provide meaningful but conceptually different data. Both types of measures are important in portraying aspects of cancer survivorship over time, although symptom burden may provide sufficient information to inform treatment decisions and identify long-term effects of cancer therapies.

Conclusions

Cancer survivors are at risk for multiple severe and persistent symptoms, and assessing and monitoring the severity and impact of these multiple symptoms is critical to understanding the survivorship experience. The inclusion of multiple symptom measures along with the development of new and better methods of long-term symptom tracking in survivors is a critical step in improving the heath status of survivors.

Implications for cancer survivors

Late and long-term effects seen in cancer survivors have historically been understudied. Symptom burden is an important area of assessment that can be used to specifically describe the symptoms that distress survivors. More descriptive data in this growing population may help identify biological processes in symptom production and maintenance, and facilitate in the development of better treatment and prevention to enhance cancer survivorship.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

Similar content being viewed by others

References

  1. Alfano, C. M., McGregor, B. A., Kuniyuki, A., Reeve, B. B., Bowen, D. J., Baumgartner, K. B., et al. (2006). Psychometric properties of a tool for measuring hormone-related symptoms in breast cancer survivors. Psychooncology, 15(11), 985–1000.

    Article  PubMed  Google Scholar 

  2. Antoni, M. H., Lehman, J. M., Kilbourn, K. M., Boyers, A. E., Culver, J. L., Alferi, S. M., et al. (2001). Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early-stage breast cancer. Health Psychology, 20(1), 20–32.

    Article  PubMed  CAS  Google Scholar 

  3. Ashing-Giwa, K. T. (2005). The contextual model of HRQoL: A paradigm for expanding the HRQoL framework. Quality of Life Research, 14(2), 297–307.

    Article  PubMed  Google Scholar 

  4. Aziz, N. M. (2002). Cancer survivorship research: Challenge and opportunity. Journal of Nutrition, 132(11 Suppl), 3494S–3503S.

    Google Scholar 

  5. Bailey, R. K., Geyen, D. J., Scott-Gurnell, K., Hipolito, M. M., Bailey, T. A., & Beal, J. M. (2005). Understanding and treating depression among cancer patients. International Journal of Gynecological Cancer, 15(2), 203–208.

    Article  PubMed  CAS  Google Scholar 

  6. Barsevick, A. M., Whitmer, K., Nail, L. M., Beck, S. L., & Dudley, W. N. (2006). Symptom cluster research: Conceptual, design, measurement, and analysis issues. Journal of Pain and Symptom Management, 31(1), 85–95.

    Article  PubMed  Google Scholar 

  7. Bender, C. M., Ergyn, F. S., Rosenzweig, M. Q., Cohen, S. M., & Sereika, S. M. (2005). Symptom clusters in breast cancer across 3 phases of the disease. Cancer Nursing, 28(3), 219–225.

    Article  PubMed  Google Scholar 

  8. Borgaonkar, M. R., & Irvine, E. J. (2000). Quality of life measurement in gastrointestinal and liver disorders. Gut, 47(3), 444–454.

    Article  PubMed  CAS  Google Scholar 

  9. Bottomley, A., Flechtner, H., Efficace, F., Vanvoorden, V., Coens, C., Therasse, P., et al. (2005). Health related quality of life outcomes in cancer clinical trials. European Journal of Cancer, 41(12), 1697–1709.

    Article  PubMed  CAS  Google Scholar 

  10. Bruera, E., Kuehn, N., Miller, M. J., Selmser, P., & Macmillan, K. (1991). The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. Journal of Palliative Care, 7(2), 6–9.

    PubMed  CAS  Google Scholar 

  11. Buchanan, D. R., O’Mara, A. M., Kelaghan, J. W., & Minasian, L. M. (2005). Quality-of-life assessment in the symptom management trials of the National Cancer Institute-supported Community Clinical Oncology Program. Journal of Clinical Oncology, 23(3), 591–598.

    Article  PubMed  Google Scholar 

  12. Bush, N. E., Haberman, M., Donaldson, G., & Sullivan, K. M. (1995). Quality of life of 125 adults surviving 6–18 years after bone marrow transplantation. Social Science & Medicine, 40(4), 479–490.

    Article  CAS  Google Scholar 

  13. Cella, D., Davis, K., Breitbart, W., & Curt, G. (2001). Cancer-related fatigue: Prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. Journal of Clinical Oncology, 19(14), 3385–3391.

    PubMed  CAS  Google Scholar 

  14. Chang, V. T., Hwang, S. S., Kasimis, B., & Thaler, H. T. (2004). Shorter symptom assessment instruments: The Condensed Memorial Symptom Assessment Scale (CMSAS). Cancer Invest, 22(4), 526–536.

    Article  PubMed  Google Scholar 

  15. Cleeland, C. S. (2001). Cancer-related fatigue: New directions for research. Introduction. Cancer, 92(6 Suppl), 1657–1661.

    Article  PubMed  CAS  Google Scholar 

  16. Cleeland, C. S. (2007). Symptom burden: Multiple symptoms and their impact as patient-reported outcomes. Journal of the National Cancer Institute, (in press).

  17. Cleeland, C. S., Bennett, G. J., Dantzer, R., Dougherty, P. M., Dunn, A. J., Meyers, C. A., et al. (2003). Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer, 97(11), 2919–2925.

    Article  PubMed  Google Scholar 

  18. Cleeland, C. S., Mendoza, T. R., Wang, X. S., Chou, C., Harle, M. T., Morrissey, M., et al. (2000). Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer, 89(7), 1634–1646.

    Article  PubMed  CAS  Google Scholar 

  19. Cleeland C. S., & Reyes-Gibby, C. C. (2002). When is it justified to treat symptoms? Measuring symptom burden. Oncology (Williston.Park), 16(9 Suppl 10), 64–70.

    Google Scholar 

  20. De Boer, A. G., Genovesi, P. I., Sprangers, M. A., Van Sandick, J. W., Obertop, H., & Van Lanschot, J. J. (2000). Quality of life in long-term survivors after curative transhiatal oesophagectomy for oesophageal carcinoma. British Journal of Surgery, 87(12), 1716–1721.

    Article  PubMed  Google Scholar 

  21. De Haes, J. C. (1988). Quality of life: Conceptual and theoretical considerations. In M. Watson, S. Greer, & C. Thomas (Eds.), Psychosocial oncology (pp. 61–70). Oxford: Pergamon.

    Google Scholar 

  22. De Haes, J. C., Van Knippenberg, F. C., & Neijt, J. P. (1990). Measuring psychological and physical distress in cancer patients: Structure and application of the Rotterdam Symptom Checklist. British Journal of Cancer, 62(6), 1034–1038.

    PubMed  Google Scholar 

  23. Dodd, M. J., Miaskowski, C., & Paul, S. M. (2001). Symptom clusters and their effect on the functional status of patients with cancer. Oncology Nursing Forum, 28(3), 465–470.

    PubMed  CAS  Google Scholar 

  24. Donnelly, S., Walsh, D., & Rybicki, L. (1995). The symptoms of advanced cancer: Identification of clinical and research priorities by assessment of prevalence and severity. Journal Of Palliative Care, 11(1), 27–32.

    PubMed  CAS  Google Scholar 

  25. Fallowfield, L., Cella, D., Cuzick, J., Francis, S., Locker, G., & Howell, A. (2004). Quality of life of postmenopausal women in the Arimidex, Tamoxifen, alone or in Combination (ATAC) Adjuvant Breast Cancer Trial. Journal of Clinical Oncology, 22(21), 4261–4271.

    Article  PubMed  CAS  Google Scholar 

  26. Fossa, S. D., Dahl, A. A., & Haaland, C. F. (1999). Health-related quality of life in patients treated for testicular cancer. British Journal of Cancer, 9(5), 425–429.

    CAS  Google Scholar 

  27. Ganz, P. A. (2001). Late effects of cancer and its treatment. Seminars in Oncology Nursing, 17(4), 241–248.

    Article  PubMed  CAS  Google Scholar 

  28. Ganz, P. A. (2006). Monitoring the physical health of cancer survivors: A survivorship-focused medical history. Journal of Clinical Oncology, 24(32), 5105–5111.

    Article  PubMed  Google Scholar 

  29. Ganz, P. A., Coscarelli, A., Fred, C., Kahn, B., Polinsky, M. L., & Petersen, L. (1996). Breast cancer survivors: Psychosocial concerns and quality of life. Breast Cancer Research and Treatment, 38(2), 183–199.

    Article  PubMed  CAS  Google Scholar 

  30. Ganz, P. A., Kwan, L., Stanton, A. L., Krupnick, J. L., Rowland, J. H., Meyerowitz, B. E., et al. (2004). Quality of life at the end of primary treatment of breast cancer: First results from the moving beyond cancer randomized trial. Journal of the National Cancer Institute, 96(5), 376–387.

    Article  PubMed  Google Scholar 

  31. Ganz, P. A., Rowland, J. H., Meyerowitz, B. E., & Desmond, K. A. (1998). Impact of different adjuvant therapy strategies on quality of life in breast cancer survivors. Recent Results in Cancer Research, 152, 396–411.

    PubMed  CAS  Google Scholar 

  32. Gaston-Johansson, F., Fall-Dickson, J. M., Bakos, A. B., & Kennedy, M. J. (1999). Fatigue, pain, and depression in pre-autotransplant breast cancer patients. Cancer Practice, 7(5), 240–247.

    Article  PubMed  CAS  Google Scholar 

  33. Grond, S., Zech, D., Diefenbach, C., & Bischoff, A. (1994). Prevalence and pattern of symptoms in patients with cancer pain: a prospective evaluation of 1635 cancer patients referred to a pain clinic. Journal of Pain and Symptom Management, 9(6), 372–382.

    Article  PubMed  CAS  Google Scholar 

  34. Grothey, A. (2005). Clinical management of oxaliplatin-associated neurotoxicity. Clinical Colorectal Cancer, 5 Suppl 1, S38–S46.

    Article  Google Scholar 

  35. Gutstein, H. B. (2001). The biologic basis of fatigue. Cancer, 92(6 Suppl), 1678–1683.

    Article  PubMed  CAS  Google Scholar 

  36. Hammerlid, E., Silander, E., Hornestam, L., & Sullivan, M. (2001). Health-related quality of life three years after diagnosis of head and neck cancer-a longitudinal study. Head and Neck, 23(2), 113–125.

    Article  PubMed  CAS  Google Scholar 

  37. Hammerlid, E., & Taft, C. (2001). Health-related quality of life in long-term head and neck cancer survivors: A comparison with general population norms. British Journal of Cancer, 84(2), 149–156.

    Article  PubMed  CAS  Google Scholar 

  38. Hart, B. L. (1988). Biological basis of the behavior of sick animals. Neuroscience and Biobehavioral Reviews, 12(2), 123–137.

    Article  PubMed  CAS  Google Scholar 

  39. Hewitt, M. E., Greenfield, S., Stovall, E. (Eds.) (2005). From cancer patient to cancer survivor: Lost in transition. Washington, DC: National Academies Press.

  40. Huguenin, P. U., Taussky, D., Moe, K., Meister, A., Baumert, B., Lutolf, U. M., et al. (1999). Quality of life in patients cured from a carcinoma of the head and neck by radiotherapy: The importance of the target volume. International Journal of Radiation Oncology, Biology, Physics, 45(1), 47–52.

    Article  PubMed  CAS  Google Scholar 

  41. Kelley, K. W., Bluthe, R. M., Dantzer, R., Zhou, J. H., Shen, W. H., Johnson, R. W., et al. (2003). Cytokine-induced sickness behavior. Brain, Behavior, and Immunity, 17 Suppl 1, S112–S118.

    Article  Google Scholar 

  42. Kent, S., Bluthe, R. M., Kelley, K. W., & Dantzer, R. (1992). Sickness behavior as a new target for drug development. Trends in Pharmacological Sciences, 13(1), 24–28.

    Article  PubMed  CAS  Google Scholar 

  43. Kim, H. J., McGuire, D. B., Tulman, L., & Barsevick, A. M. (2005). Symptom clusters: Concept analysis and clinical implications for cancer nursing. Cancer Nursing, 28(4), 270–282.

    Article  PubMed  Google Scholar 

  44. Kirkova, J., Davis, M. P., Walsh, D., Tiernan, E., O'Leary, N., LeGrand, S. B., et al. (2006). Cancer symptom assessment instruments: A systematic review. Journal of Clinical Oncology, 24(9), 1459–1473.

    Article  PubMed  Google Scholar 

  45. Klinkenberg, M., Willems, D. L., van der, W. G., & Deeg, D. J. (2004). Symptom burden in the last week of life. Journal of Pain and Symptom Management, 27(1), 5–13.

    Article  PubMed  Google Scholar 

  46. Kurzrock, R. (2001). The role of cytokines in cancer-related fatigue. Cancer, 92(6 Suppl), 1684–1688.

    Article  PubMed  CAS  Google Scholar 

  47. Lee, B. N., Dantzer, R., Langley, K. E., Bennett, G. J., Dougherty, P. M., Dunn, A. J., et al. (2004). A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomodulation, 11(5), 279–292.

    Article  PubMed  CAS  Google Scholar 

  48. Miaskowski, C., Dodd, M., & Lee, K. (2004). Symptom clusters: the new frontier in symptom management research. Journal of the National Cancer Institute. Monographs, 32, 17–21.

    Google Scholar 

  49. Miaskowski, C., & Lee, K. A. (1999). Pain, fatigue, and sleep disturbances in oncology outpatients receiving radiation therapy for bone metastasis: A pilot study. Journal of Pain and Symptom Management, 17(5), 320–332.

    Article  PubMed  CAS  Google Scholar 

  50. Mols, F., Vingerhoets, A. J., Coebergh, J. W., & van de Poll-Franse L. V. (2005). Quality of life among long-term breast cancer survivors: A systematic review. European Journal of Cancer, 41(17), 2613–2619.

    Article  PubMed  Google Scholar 

  51. Paice, J. A. (2004). Assessment of symptom clusters in people with cancer. Journal of the National Cancer Institute. Monographs, 32, 98–102.

    Google Scholar 

  52. Patrick, D. L., Ferketich, S. L., Frame, P. S., Harris, J. J., Hendricks, C. B., Levin, B., et al. (2004). National Institutes of Health State-of-the-Science Conference Statement: Symptom management in cancer: Pain, depression, and fatigue, July 15–17, 2002. Journal of the National Cancer Institute. Monographs, 32, 9–16.

    Google Scholar 

  53. Portenoy, R. K., Thaler, H. T., Kornblith, A. B., Lepore, J. M., Friedlander-Klar, H., Kiyasu, E., et al. (1994). The Memorial Symptom Assessment Scale: An instrument for the evaluation of symptom prevalence, characteristics and distress. European Journal of Cancer, 30A(9), 1326–1336.

    Article  PubMed  CAS  Google Scholar 

  54. Rauch, P., Miny, J., Conroy, T., Neyton, L., & Guillemin, F. (2004). Quality of life among disease-free survivors of rectal cancer. Journal of Clinical Oncology, 22(2), 354–360.

    Article  PubMed  Google Scholar 

  55. Reyes-Gibby, C. C., Aday, L. A., Anderson, K. O., Mendoza, T. R., & Cleeland, C. S. (2006). Pain, depression, and fatigue in community-dwelling adults with and without a history of cancer. Journal of Pain and Symptom Management, 32(2), 118–128.

    Article  PubMed  Google Scholar 

  56. Ross, J. R., Goller, K., Hardy, J., Riley, J., Broadley, K., A’hern, R., et al. (2005). Gabapentin is effective in the treatment of cancer-related neuropathic pain: A prospective, open-label study. Journal of Palliative Medicine, 8(6), 1118–1126.

    Article  PubMed  CAS  Google Scholar 

  57. Rudberg, L., Carlsson, M., Nilsson, S., & Wikblad, K. (2002). Self-perceived physical, psychologic, and general symptoms in survivors of testicular cancer 3 to 13 years after treatment. Cancer Nursing, 25(3), 187–195.

    Article  PubMed  Google Scholar 

  58. Schwartz, C. E., & Sprangers, M. A. (1999). Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research. Social Science & Medicine, 48(11), 1531–1548.

    Article  CAS  Google Scholar 

  59. Silveira, M. J., Kabeto, M. U., & Langa, K. M. (2005). Net worth predicts symptom burden at the end of life. Journal of Palliative Medicine, 8(4), 827–837.

    Article  PubMed  Google Scholar 

  60. Sprangers, M. A. G., & Schwartz, C. E. (1999). Integrating response shift into health-related quality of life research: A theoretical model. Social Science & Medicine, 48(11), 1507–1515.

    Article  CAS  Google Scholar 

  61. Steineck, G., Bergmark, K., Henningsohn, L., al-Abany, M., Dickman, P. W., & Helgason, A. (2002). Symptom documentation in cancer survivors as a basis for therapy modifications. Acta Oncologica, 41(3), 244–252.

    Article  PubMed  Google Scholar 

  62. Valentine, A. D., & Meyers, C. A. (2001). Cognitive and mood disturbance as causes and symptoms of fatigue in cancer patients. Cancer, 92(6 Suppl), 1694–1698.

    Article  PubMed  CAS  Google Scholar 

  63. Van Weert, E., Hoekstra-Weebers, J., Grol, B., Otter, R., Arendzen, H. J., Postema, K., et al. (2005). A multidimensional cancer rehabilitation program for cancer survivors: Effectiveness on health-related quality of life. Journal of Psychosomatic Research, 58(6), 485–496.

    Article  PubMed  Google Scholar 

  64. Wang, X. S., Fairclough, D. L., Liao, Z., Komaki, R., Chang, J. Y., Mobley, G. M., et al. (2006). Longitudinal study of the relationship between chemoradiation therapy for non-small-cell lung cancer and patient symptoms. Journal of Clinical Oncology, 24(27), 4485–4491.

    Article  PubMed  Google Scholar 

  65. Webster’s Third New International Dictionary of the English Language, U. (1966). (15th ed.) Springfield, MA: Merriam.

  66. Zambroski, C. H., Moser, D. K., Bhat, G., & Ziegler, C. (2005). Impact of symptom prevalence and symptom burden on quality of life in patients with heart failure. European Journal of Cardiovascular Nursing, 4(3), 198–206.

    Article  PubMed  Google Scholar 

Download references

Acknowledgement

The authors would like to thank Jeanie Woodruff, ELS, for assistance in organizing and editing of the manuscript.

Author information

Authors and Affiliations

  1. The Department of Symptom Research, The University of Texas M. D. Anderson Cancer Center, 1100 Holcombe Blvd., Unit 221, Houston, TX, 77030, USA

    V. Shannon Burkett & Charles S. Cleeland

Authors
  1. V. Shannon Burkett
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Charles S. Cleeland
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to V. Shannon Burkett.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Burkett, V.S., Cleeland, C.S. Symptom burden in cancer survivorship. J Cancer Surviv 1, 167–175 (2007). https://doi.org/10.1007/s11764-007-0017-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11764-007-0017-y

Keywords

Search

Navigation